ClinicalTrials.gg
Active, not recruitingNCT05683756OASISUpdated Jun 9, 2026

Optimizing Attention and Sleep Intervention Study

An interventional study of Brief Parent Behavioral Intervention and Sleep-Focused Parent Behavioral Intervention in Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Hyperactivity Disorder and Child, Preschool, sponsored by University of Pittsburgh. Active, not recruiting at 7 sites in United States. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-06-09.

Primary conditionAttention Deficit Disorder with HyperactivityRegistry: Attention Deficit and Disruptive Behavior DisordersReclassifiedWhy we changed it
Registry
Attention Deficit and Disruptive Behavior Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Attention Deficit Disorder with Hyperactivity
Why
  1. The study's listed conditions name Attention Deficit Disorder with Hyperactivity, a narrower term within Attention Deficit and Disruptive Behavior Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh — 2 open to participants now, 4 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · University of Pittsburgh.

Planned enrollment
5th of 10
50 · median 43
Started
2023
the only one that year
No phase
7 of 10
2 open now
Registered
7th of 10
by date

Among the 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh, this one is the 5th largest by planned enrollment, is the only one that started in 2023, is one of 7 with no phase, and was the 7th registered.

Attention Deficit Disorder with Hyperactivity

1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.

Browse Attention Deficit Disorder with Hyperactivity studies →

Open to participants now

2 of the 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.

This study: 3 Years to 5 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh, or all of them as a file.
02

Study summary

The goal of this pilot clinical effectiveness trial is to compare a brief parent behavioral intervention (PBI) to a modified sleep focused PBI (SF-PBI) delivered by therapists in pediatric primary care for families of children 3-5 years old with sleep problems and early ADHD symptoms.

The main aims are to:

Aim 1: Demonstrate the acceptability, feasibility, and appropriateness of the sleep focused PBI (SF-PBI) delivered in pediatric primary care for preschool-aged children (3-5 years old) at elevated risk for ADHD.

Aim 2: Examine change in target engagement (sleep) and ADHD symptoms among preschool-aged children at elevated risk for ADHD receiving SF-PBI compared to standard PBI.

Read the detailed description

Sleep problems may be one mechanism through which young children may be at risk for developing ADHD, although first line ADHD interventions, including parent behavioral interventions (PBIs), do not address sleep. Investigators will test a modified version of a PBI to target sleep disrupting behaviors for children 3-5 years old at elevated risk for ADHD. The intervention will be delivered by behavioral health therapists embedded in pediatric primary care to increase families' access to intervention. This pilot effectiveness trial is the first step towards developing an early intervention targeting sleep as a mechanism to reduce the prevalence, symptoms, and impairments associated with childhood ADHD.

03

Conditions studied

  • Attention Deficit and Disruptive Behavior Disorders
  • Attention Deficit Hyperactivity Disorder
  • Child, Preschool
  • Sleep
  • Sleep Disturbance
04

In context

Attention Deficit Disorder with Hyperactivity Reclassified

1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.

This study's planned enrollment of 50 is below the median of 72 across 1,439 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Compared within Attention Deficit Disorder with Hyperactivity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Attention Deficit and Disruptive Behavior Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Parent/Caregiver:

  • (1) Legal guardian is at least 18 years of age
  • (2) Reads and speaks English

Child:

  • (1) 3-5 years of age
  • (2) Caregiver report of 4 or more ADHD symptoms
  • (3) Caregiver reports child's sleep as a "moderate" or "serious problem"
  • (4) English speaking
  • (5) Child receives care from participating pediatric primary care office

Exclusion criteria

Exclusion Criteria:

  • (1) Sleep interfering medical diagnoses (e.g., narcolepsy, obstructive sleep apnea)
  • (2) Severe neurodevelopmental disorder
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Brief Parent Behavioral Intervention

    A brief parent behavioral intervention with evidenced based strategies for treatment of ADHD.

    Behavioral: Brief Parent Behavioral Intervention

  • Experimental
    Sleep-Focused Parent Behavioral Intervention

    A modified version of the brief parent behavioral intervention that specifically targets sleep disrupting behaviors.

    Behavioral: Sleep-Focused Parent Behavioral Intervention

Interventions

  • BehavioralBrief Parent Behavioral Intervention

    PBI administered in pediatric primary care by an embedded therapist.

  • BehavioralSleep-Focused Parent Behavioral Intervention

    SF-PBI administered in pediatric primary care by an embedded therapist.

07

What researchers measure

Primary outcomes

  1. Intervention Acceptability

    Therapists and caregiver report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good acceptability.

    Time frame: Post Intervention at approximately 4 months

  2. Intervention Appropriateness

    Therapists and caregiver report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good appropriateness.

    Time frame: Post Intervention at approximately 4 months

  3. Intervention Feasibility

    Therapists and caregiver report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good feasibility.

    Time frame: Post Intervention at approximately 4 months

  4. Problematic Sleep

    Using the Brief Child Sleep Questionnaire caregivers will report on their perception of child's sleep as problematic, rated 1 (Not at all) to 5 (A serious problem).

    Time frame: Change from baseline up to 8 months

  5. ADHD Symptoms

    Using the 18-item ADHD Rating Scale-IV-Preschool Version caregivers will report on the child's ADHD symptoms. Symptoms are rated from 0 (Rarely) to 3 (Very Often).

    Time frame: Change from baseline up to 8 months

Secondary outcomes

  1. Nighttime Awakenings

    Caregivers will report how many times their child typically wakes during the night, using the Brief Child Sleep Questionnaire.

    Time frame: Change from baseline up to 8 months

  2. Sleep Latency

    Sleep latency will be determined by using the caregiver report of how long it typically takes their child to fall asleep (number of minutes), using the Brief Child Sleep Questionnaire.

    Time frame: Change from baseline up to 8 months

  3. Consistency of Bedtime Routine

    Caregivers will report the number of days, in a typical week, they regularly put their child to bed at the same time (within 15 minutes), using the Brief Child Sleep Questionnaire.

    Time frame: Change from baseline up to 8 months

Other outcomes

  1. Actigraphy

    Actigraphy is collected for 10 days at each of the three study timepoints. These data are to assess feasibility of actigraphy data collection with this population and will be used in exploratory analyses.

    Time frame: Change from baseline up to 8 months

  2. Sleep Diary

    Sleep diary is collected for 10 days at each of the three study timepoints. These data are to assess feasibility of parent reported sleep diary data collection with this population and will be used in exploratory analyses.

    Time frame: Change from baseline up to 8 months

08

Study locations

7 sites
  • Children's Community Pediatrics Bass Wolfson, Cranberry
    Cranberry Township, Pennsylvania 16066, United States
  • Children's Community Pediatrics GIL Murrysville
    Monroeville, Pennsylvania 15146, United States
  • Children's Community Pediatrics Shenango
    New Castle, Pennsylvania 16101, United States
  • Children's Community Pediatrics Neshannock
    New Castle, Pennsylvania 16105, United States
  • Children's Community Pediatrics GIL East Liberty
    Pittsburgh, Pennsylvania 15206, United States
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
  • Children's Community Pediatrics Bass Wolfson, Squirrel Hill
    Pittsburgh, Pennsylvania 15217, United States
09

References and documents

Publications

  • Cunningham CE, Bremner R, Boyle M. Large group community-based parenting programs for families of preschoolers at risk for disruptive behaviour disorders: utilization, cost effectiveness, and outcome. J Child Psychol Psychiatry. 1995 Oct;36(7):1141-59. doi: 10.1111/j.1469-7610.1995.tb01362.x. PubMed 8847377 ↗
  • Joseph HM, Levenson JC, Conlon RPK, Mannion K, Kipp HL, Gradian A, Wallace ML, Williamson AA. Optimizing Attention and Sleep Intervention Study (OASIS): a protocol for a pilot randomized controlled trial to compare parent behavioral interventions with and without sleep strategies delivered in pediatric primary care for preschool-aged children at risk of childhood ADHD. Pilot Feasibility Stud. 2025 Feb 25;11(1):22. doi: 10.1186/s40814-025-01600-0. PubMed 40001155 ↗

Individual participant data

Plan to share: Yes — Individual participant data collected during the trial will be shared, after deidentification, via the NIMH National Data Archive.

Supporting information: Study protocol

Time frame: Data will be shared upon publication or 1 year after the grant end date. Data will be available indefinitely.

Access criteria: Any NIMH NDA authorized users may request the data.

Data sharing details ↗ · nda.nih.gov

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.

Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 36 months is above that.

Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 24, 2022
First posted
Jan 13, 2023
StartActual
Dec 1, 2023
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jun 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05683756
Responsible party
Heather Joseph (Assistant Professor, University of Pittsburgh) — Principal investigator
First posted
Jan 13, 2023
Start date
Dec 1, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 9, 2026

Study contacts

Heather M Joseph, DO
principal investigator · Assistant Professor of Psychiatry and Pediatrics, University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion